Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using 18F-FDG PET/CT and/or routine iliac crest biopsy? A new approach of PET/CT-guided targeted bone marrow biopsy

Table 6 Analysis of the 34 PET/CT-guided targeted BMBs for PET-assessed staging IV patients

Biopsy site	No. of biopsies	Biopsy procedure			Diagnosis		Bone morpholovic abnormalities on CT findings
		Success	Complications		Subtype^a	Other^b	No. of Yes	No. of No
		Success	Slight pain	Slight bleeding	Subtype^a	Other^b	No. of Yes	No. of No
Ilium	22	22	15	15	19	3	15	8
Sacrum	6	6	5	4	6	0	1	5
Ischium	3	3	3	3	3	0	1	1
Rib	1	1	0	0	1	0	1	0
Femur	2	2	2	2	2	0	1	1
Total	34	34	25	24	31	3	19	15

^aSubtype means definite subtype diagnosis, such as diffuse large B cell lymphoma
^bOther include one Eosinophilic granuloma with fibrosis, one myelodysplastic syndrome (MDS) and one active bone marrow hyperplasia

ISSN: 1471-2407